BIOMERICA INC BMRA
COM NEW · Common Stock · CUSIP 09061H307
- SectorHealth care
- IndustryIn Vitro & In Vivo Diagnostic Substances
- HeadquartersIrvine, CA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 32 |
| Q4 2022 | 31 |
| Q1 2023 | 35 |
| Q2 2023 | 37 |
| Q3 2023 | 36 |
| Q4 2023 | 34 |
| Q1 2024 | 37 |
| Q2 2024 | 36 |
| Q3 2024 | 26 |
| Q4 2024 | 22 |
| Q1 2025 | 23 |
| Q2 2025 | 0 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q3 2023 | 8 | 17 |
| Q4 2023 | 17 | 14 |
| Q1 2024 | 18 | 11 |
| Q2 2024 | 11 | 16 |
| Q3 2024 | 3 | 25 |
| Q4 2024 | 6 | 13 |
| Q1 2025 | 8 | 10 |
| Q2 2025 | 0 | 23 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2024 | $17.6k | $0 | 0.00 |
| Q4 2024 | $7.0k | $0 | 0.00 |
| Q1 2025 | $32.5k | $65.7k | 2.02 |
| Q2 2025 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -169.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -156.6k |
| BlackRock, Inc. | Sold out | -149.1k |
| Bulltick Wealth Management, LLC | Sold out | -137.1k |
| Granahan Investment Management, LLC | Sold out | -88.0k |
| TWO SIGMA INVESTMENTS, LP | Sold out | -42.4k |
| STATE STREET CORP | Sold out | -37.2k |
| NewEdge Advisors, LLC | Sold out | -29.1k |
| TWO SIGMA SECURITIES, LLC | Sold out | -23.5k |
| NORTHERN TRUST CORP | Sold out | -20.7k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
BRC Group Holdings, Inc.
13D · may seek influence
new · filed 2026-08-28
Stated purpose(a) - (j) The Purchased Shares were acquired by the Reporting Persons for investment purposes, and such purchases were made in the ordinary course of business of the Reporting Persons. In pursuing such investment purposes, the Reporting Persons may further purchase, hold, vote, trade, dispose or otherwise deal in the Common Stock at times, and in such manner, as they deem advisable to benefit from, among other things, (1) changes in the market prices of the shares of Common Stock; (2) changes in the Issuer's operations, business strategy or prospects; or (3) from the sale or merger of the Issuer. To evaluate such alternatives, the Reporting Persons will closely monitor the Issuer's operations, prospects, business development, management, competitive and strategic matters, capital structu… Full filing |
10.0% |
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|